患有胎儿生长限制的患者的血管性失衡,炎症和氧化应激:一个病例对照研究
Mehwish Iftikhar1,2, Sumaira Sharif1, Sawar Khan3
1Institute of Molecular Biology and Biotechnology, The University of Lahore, Pakistan.
African journal of reproductive health
|October 6, 2025
概括
胎儿生长限制 (FGR) 涉及降低血管内皮生长因子 (VEGF) 和增加可溶性FMS类型的氨酸激酶-1 (sFlt-1),与氧化应激和炎症有关. 这些发现表明FGR的新治疗目标.
科学领域:
- 产科和妇科 产科和妇科
- 周围生理学 周围生理学
- 分子生物学分子生物学
背景情况:
- 胎儿生长限制 (FGR) 是一个具有重大胎儿风险的重大产科并发症.
- FGR的病理生理学涉及血管新生,炎症和氧化应激途径之间的复杂相互作用.
研究的目的:
- 调查FGR.中的血管生成因子和炎症性细胞因子的表达.
- 检查这些因素与FGR怀孕中的母体氧化应激标志物之间的关联.
主要方法:
- 实时PCR用于分析外围血液单核细胞 (PBMC) 中的信使RNA (mRNA) 表达.
- 光谱测定和ELISA测量了母体血液中的氧化应激标志物.
- 该研究包括75例FGR病例和75例健康怀孕.
主要成果:
- FGR病例显示血管内皮生长因子 (VEGF) 降低,FMS类可溶性氨酸激酶-1 (sFlt-1) 和核因子-卡帕B (NF-κB) 表达增加.
- sFlt-1水平与VEGF和胎盘生长因子 (PlGF) 相反相关.
- sFlt-1和NF-κB的表达与氧化应激标志物如马隆迪甲基 (MDA) 和8-基-2'-脱氧氨酸 (8-OHdG) 有积极的相关性.
结论:
- FGR的特点是血管生成信号受损,氧化应激增加和炎症.
- 孕产妇的氧化应激和炎症与FGR中的血管原因子表达变化密切相关.
- 针对氧化应激和炎症可能提供改善FGR结果的治疗策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K


